MétaCan
Menu
Back to cohort

COVID-19-vaccination in patients receiving allergen immunotherapy (AIT) or biologics - EAACI recommendations

2021· preprint· en· W3174397041 on OpenAlexaff
Marek Jutel, Marı́a José Torres, Óscar Palomares, Cezmi A. Akdiş, Thomas Eiwegger, Eva Untersmayr, Domingo Barber, Magdalena Zemelka‐Wiącek, Anna Kosowska, Elizabeth Palmer, Stefan Vieths, Vera Mahler, Giorgio Walter Canonica, Kari C. Nadeau, Mohamed H. Shamji, Ioana Agache, Mübeccel Akdiş, Musa Khaitov, Alberto Álvarez‐Perea, Montserrat Álvaro‐Lozano, Marina Atanasković‐Marković, Vibeke Backer, A. Barbaud, Sevim Bavbek, F. de Blay, Matteo Bonini, С. Бонини, Job F. M. van Boven, Knut Brockow, Mario Cazzola, Alexia Chatzipetrou, Tomás Chivato, Antonella Cianferoni, Jonathan Corren, Jean‐Christoph Caubet, Audrey DunnGalvin, Motohiro Ebisawa, Davide Firinu, Radosław Gawlik, Aslı Gelincik, Stefano Del Giacco, Charlotte G. Mørtz, Hans Jürgen Hoffmann, Karin Hoffmann‐Sommergruber, Ludger Klimek, Antti Lauerma, Luis Pérez de Llano, Andrea Matucci, Rosan Meyer, André Moreira, Hideaki Morita, Sarita U. Patil, Oliver Pfaar, Florin‐Dan Popescu, Victoria del Pozo, Oliver J. Price, Ronald van Ree, Montserrat Fernández‐Rivas, Barbara Rogala, Antonino Romano, Alexandra F. Santos, Anna Šedivá, Isabel Skypala, Sylwia Smolińska, Milena Sokołowska, Gunter J. Sturm, Alessandra Vultaggio, Jolanta Walusiak‐Skorupa, Margitta Worm

Bibliographic record

Venuenot available
Typepreprint
Languageen
FieldMedicine
TopicAllergic Rhinitis and Sensitization
Canadian institutionsHospital for Sick Children
Fundersnot available
KeywordsMedicineImmunologyVaccinationPandemicAllergen immunotherapyImmune systemAllergyImmunotherapyAsthmaCoronavirus disease 2019 (COVID-19)Intensive care medicineInternal medicineInfectious disease (medical specialty)Disease

Abstract

fetched live from OpenAlex

Immune modulation is a key therapeutic tool for allergic diseases and asthma. It can be achieved in an antigen-specific way via allergen immunotherapy (AIT) or in endotype-driven approach using biologicals that target the major pathways of the type 2 (T2) immune response: IgE, IL-5 and IL-4/IL-13. COVID-19 vaccine provides an excellent opportunity to tackle the global pandemics and is currently being applied in an accelerated rhythm worldwide. It works as well through immune modulation. Thus, as there is an obvious interference between these treatment modalities recommendations on how they should be applied in sequence are expected. The European Academy of Allergy and Clinical Immunology (EAACI) gathered an outstanding expert panel under its Research and Outreach Committee (ROC). This expert panel was called to evaluate the evidence and formulate recommendation on the administration of COVID-19 vaccine in patients with allergic diseases and asthma receiving AIT or biologicals. The panel also formulated recommendations for COVID-19 vaccine in association with biologicals targeting the type 1 or type 3 immune response. In formulating recommendations, the panel evaluated the mechanisms of COVID-19 infection, of COVID-19 vaccine, of AIT and of biologicals and considered the data published for other anti-infectious vaccines administered concurrently with AIT or biologicals.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.010
metaresearch head score (Gemma)0.024
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Other · Consensus signal: none
Teacher disagreement score0.013
Threshold uncertainty score0.052

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0100.024
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0040.004
Insufficient payload (model declined to judge)0.0130.009

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.057
GPT teacher head0.340
Teacher spread0.284 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2021
Admission routes1
Has abstractyes

Explore more

Same topicAllergic Rhinitis and SensitizationFrench-language works237,207